{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:09:46Z","timestamp":1787508586859,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T00:00:00Z","timestamp":1576454400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"China Post-Doctoral Science Foundation","award":["2019TQ0219"],"award-info":[{"award-number":["2019TQ0219"]}]},{"name":"Post-Doctor Research Project, West China Hospital, Sichuan University","award":["2019HXBH019"],"award-info":[{"award-number":["2019HXBH019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10741-019-09905-y","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T04:04:07Z","timestamp":1576469047000},"page":"91-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Pulmonary vasodilator therapy after the Fontan procedure: a meta-analysis"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2630-4286","authenticated-orcid":false,"given":"Dongxu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,16]]},"reference":[{"key":"9905_CR1","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1007\/s00246-017-1595-8","volume":"38","author":"D Li","year":"2017","unstructured":"Li D, Fan Q, Hirata Y, Ono M, An Q (2017) Arrhythmias after Fontan operation with intra-atrial lateral tunnel versus extra-cardiac conduit: a systematic review and meta-analysis. Pediatr Cardiol 38:873\u2013880","journal-title":"Pediatr Cardiol"},{"key":"9905_CR2","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1136\/thx.26.3.240","volume":"26","author":"F Fontan","year":"1971","unstructured":"Fontan F, Baudet E (1971) Surgical repair of tricuspid atresia. Thorax 26:240\u2013248","journal-title":"Thorax"},{"issue":"3 Pt 2","key":"9905_CR3","first-page":"III53","volume":"76","author":"FJ Puga","year":"1987","unstructured":"Puga FJ, Chiavarelli M, Hagler DJ (1987) Modifications of the Fontan operation applicable to patients with left atrioventricular valve atresia or single atrioventricular valve. Circulation 76(3 Pt 2):III53\u2013III60","journal-title":"Circulation"},{"key":"9905_CR4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0022-5223(19)35174-8","volume":"96","author":"MR de Leval","year":"1988","unstructured":"de Leval MR, Kilner P, Gewillig M, Bull C (1988) Total cavopulmonary connection: a logical alternative to atriopulmonary connection for complex Fontan operations. Experimental studies and early clinical experience J Thorac Cardiovasc Surg 96:682\u2013695","journal-title":"Experimental studies and early clinical experience J Thorac Cardiovasc Surg"},{"key":"9905_CR5","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1161\/01.CIR.86.6.1762","volume":"86","author":"ND Bridges","year":"1992","unstructured":"Bridges ND, Mayer JE Jr, Lock JE et al (1992) Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation 86:1762\u20131769","journal-title":"Circulation"},{"key":"9905_CR6","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1053\/j.pcsu.2011.01.010","volume":"14","author":"RA Jonas","year":"2011","unstructured":"Jonas RA (2011) The intra\/extracardiac conduit fenestrated Fontan. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 14:11\u201318","journal-title":"Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu"},{"key":"9905_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jacc.2008.02.081","volume":"52","author":"SM Paridon","year":"2008","unstructured":"Paridon SM, Mitchell PD, Colan SD, Williams RV, Blaufox A, Li JS, Margossian R, Mital S, Russell J, Rhodes J, Pediatric Heart Network Investigators (2008) A cross-sectional study of exercise performance during the first 2 decades of life after the Fontan operation. J Am Coll Cardiol 52:99\u2013107","journal-title":"J Am Coll Cardiol"},{"key":"9905_CR8","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1510\/icvts.2009.218594","volume":"10","author":"M Gewillig","year":"2010","unstructured":"Gewillig M, Brown SC, Eyskens B, Heying R, Ganame J, Budts W, la Gerche A, Gorenflo M (2010) The Fontan circulation: who controls cardiac output? Interact Cardiovasc Thorac Surg 10:428\u2013433","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"9905_CR9","doi-asserted-by":"publisher","unstructured":"La Gerche A, Gewillig M (2010) What limits cardiac performance during exercise in normal subjects and in healthy Fontan patients? Int J Pediatr. https:\/\/doi.org\/10.1155\/2010\/791291","DOI":"10.1155\/2010\/791291"},{"key":"9905_CR10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1017\/S1047951115002747","volume":"26","author":"NJ Oldenburger","year":"2016","unstructured":"Oldenburger NJ, Mank A, Etnel J, Takkenberg JJ, Helbing WA (2016) Drug therapy in the prevention of failure of the Fontan circulation: a systematic review. Cardiol Young 26:842\u2013850","journal-title":"Cardiol Young"},{"key":"9905_CR11","first-page":"885","volume":"52","author":"MS Siobal","year":"2007","unstructured":"Siobal MS (2007) Pulmonary vasodilators. Respir Care 52:885\u2013899","journal-title":"Respir Care"},{"key":"9905_CR12","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 339:b2535","journal-title":"BMJ"},{"key":"9905_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000017615","volume":"98","author":"D Li","year":"2019","unstructured":"Li D, Zhou X, An Q, Feng Y (2019) Pulmonary vasodilator therapy for patients after Fontan procedure: a protocol for a systematic review and meta-analysis. Medicine 98:e17615","journal-title":"Medicine"},{"key":"9905_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1136\/jech.52.6.377","volume":"52","author":"SH Downs","year":"1998","unstructured":"Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health 52:377\u2013384","journal-title":"J Epidemiol Community Health"},{"key":"9905_CR15","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC et al (2011) The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ 343:d5928","journal-title":"BMJ"},{"key":"9905_CR16","unstructured":"Higgins JP, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1. The Cochrane Collaboration. http:\/\/handbook-5-1.cochrane.org\/. ."},{"key":"9905_CR17","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cct.2006.04.004","volume":"28","author":"R DerSimonian","year":"2007","unstructured":"DerSimonian R, Kacker R (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28:105\u2013114","journal-title":"Contemp Clin Trials"},{"key":"9905_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"JP Higgins","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557\u2013560","journal-title":"BMJ"},{"key":"9905_CR19","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1161\/CIRCULATIONAHA.113.008441","volume":"130","author":"A Hebert","year":"2014","unstructured":"Hebert A, Mikkelsen UR, Thilen U, Idorn L, Jensen AS, Nagy E, Hanseus K, S\u00f8rensen KE, S\u00f8ndergaard L (2014) Bosentan improves exercise capacity in adolescents and adults after Fontan operation: the TEMPO (treatment with endothelin receptor antagonist in Fontan patients, a randomized, placebo-controlled, double-blind study measuring peak oxygen consumption) study. Circulation 130:2021\u20132030","journal-title":"Circulation"},{"key":"9905_CR20","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/eurjhf\/hft017","volume":"15","author":"MJ Schuuring","year":"2013","unstructured":"Schuuring MJ, Vis JC, van Dijk AP, van Melle J, Vliegen HW, Pieper PG, Sieswerda GT, de Bruin-Bon RH, Mulder BJ, Bouma BJ (2013) Impact of bosentan on exercise capacity in adults after the Fontan procedure: a randomized controlled trial. Eur J Heart Fail 15:690\u2013698","journal-title":"Eur J Heart Fail"},{"key":"9905_CR21","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s11596-016-1621-8","volume":"36","author":"XK Shang","year":"2016","unstructured":"Shang XK, Lu R, Zhang X et al (2016) Efficacy of Bosentan in patients after Fontan procedures: a double-blind, randomized controlled trial. J Huazhong Univ Sci Technolog Med Sci 36:534\u2013540","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"9905_CR22","first-page":"1025","volume":"41","author":"XK Shang","year":"2013","unstructured":"Shang XK, Li YP, Liu M, Zhou HM, Peng T, Deng XX, Tao L, Zhang GC (2013) Efficacy of endothelin receptor antagonist bosentan on the long-term prognosis in patients after Fontan operation. Zhonghua Xin Xue Guan Bing Za Zhi 41:1025\u20131028","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"9905_CR23","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1161\/CIRCULATIONAHA.110.981746","volume":"123","author":"DJ Goldberg","year":"2011","unstructured":"Goldberg DJ, French B, McBride MG, Marino BS, Mirarchi N, Hanna BD, Wernovsky G, Paridon SM, Rychik J (2011) Impact of oral sildenafil on exercise performance in children and young adults after the Fontan operation: a randomized, double-blind, placebo-controlled, crossover trial. Circulation 123:1185\u20131193","journal-title":"Circulation"},{"key":"9905_CR24","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1017\/S1047951114001772","volume":"25","author":"A Mendoza","year":"2015","unstructured":"Mendoza A, Albert L, Belda S, Casanueva L, Herrera D, Granados MA, Velasco JM, Garc\u00eda E, Aguilar JM, Comas JV (2015) Pulmonary vasodilator therapy and early postoperative outcome after modified Fontan operation. Cardiol Young 25:1136\u20131140","journal-title":"Cardiol Young"},{"key":"9905_CR25","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1093\/eurheartj\/ehn215","volume":"29","author":"A Giardini","year":"2008","unstructured":"Giardini A, Balducci A, Specchia S, Gargiulo G, Bonvicini M, Picchio FM (2008) Effect of sildenafil on haemodynamic response to exercise and exercise capacity in Fontan patients. Eur Heart J 29:1681\u20131687","journal-title":"Eur Heart J"},{"key":"9905_CR26","doi-asserted-by":"publisher","first-page":"552","DOI":"10.2459\/JCM.0b013e328361390a","volume":"16","author":"R Giordano","year":"2015","unstructured":"Giordano R, Palma G, Poli V et al (2015) First experience with sildenafil after Fontan operation: short-term outcomes. J Cardiovasc Med (Hagerstown) 16:552\u2013555","journal-title":"J Cardiovasc Med (Hagerstown)"},{"key":"9905_CR27","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1007\/s00246-017-1716-4","volume":"38","author":"JLG Collins","year":"2017","unstructured":"Collins JLG, Law MA, Borasino S, Erwin WC, Cleveland DC, Alten JA (2017) Routine sildenafil does not improve clinical outcomes after Fontan operation. Pediatr Cardiol 38:1703\u20131708","journal-title":"Pediatr Cardiol"},{"key":"9905_CR28","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1016\/j.amjcard.2016.02.024","volume":"117","author":"AM Cedars","year":"2016","unstructured":"Cedars AM, Saef J, Peterson LR, Coggan AR, Novak EL, Kemp D, Ludbrook PA (2016) Effect of ambrisentan on exercise capacity in adult patients after the Fontan procedure. Am J Cardiol 117:1524\u20131532","journal-title":"Am J Cardiol"},{"key":"9905_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/j.1442-200X.2003.01800.x","volume":"45","author":"K Takahashi","year":"2003","unstructured":"Takahashi K, Mori Y, Yamamura H, Nakanishi T, Nakazawa M (2003) Effect of beraprost sodium on pulmonary vascular resistance in candidates for a Fontan procedure: a preliminary study. Pediatr Int 45:671\u2013675","journal-title":"Pediatr Int"},{"key":"9905_CR30","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ahj.2017.02.030","volume":"188","author":"DJ Goldberg","year":"2017","unstructured":"Goldberg DJ, Zak V, Goldstein BH, Chen S, Hamstra MS, Radojewski EA, Maunsell E, Mital S, Menon SC, Schumacher KR, Payne RM, Stylianou M, Kaltman JR, deVries T, Yeager JL, Paridon SM, Pediatric Heart Network Investigators (2017) Results of a phase I\/II multi-center investigation of udenafil in adolescents after Fontan palliation. Am Heart J 188:42\u201352","journal-title":"Am Heart J"},{"key":"9905_CR31","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1016\/j.ijcard.2013.03.014","volume":"168","author":"J Rhodes","year":"2013","unstructured":"Rhodes J, Ubeda-Tikkanen A, Clair M, Fernandes SM, Graham DA, Milliren CE, Daly KP, Mullen MP, Landzberg MJ (2013) Effect of inhaled iloprost on the exercise function of Fontan patients: a demonstration of concept. Int J Cardiol 168:2435\u20132440","journal-title":"Int J Cardiol"},{"key":"9905_CR32","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00246-015-1238-x","volume":"37","author":"MR Sabri","year":"2016","unstructured":"Sabri MR, Zolfi-Gol A, Ahmadi A, Haghjooy-Javanmard S (2016) Effect of tadalafil on myocardial and endothelial function and exercise performance after modified Fontan operation. Pediatr Cardiol 37:55\u201361","journal-title":"Pediatr Cardiol"},{"key":"9905_CR33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/rcm.rcm_7_18","volume":"7","author":"Z Khajali","year":"2018","unstructured":"Khajali Z, Peighambari MM, Lotfian S et al (2018) Tadalafil and exercise capacity after Fontan operation. Res Cardiovasc Med 7:64\u201368","journal-title":"Res Cardiovasc Med"},{"key":"9905_CR34","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1001\/jama.2013.285063","volume":"311","author":"X Sun","year":"2014","unstructured":"Sun X, Ioannidis JP, Agoritsas T, Alba AC, Guyatt G (2014) How to use a subgroup analysis: users\u2019 guide to the medical literature. JAMA 311:405\u2013411","journal-title":"JAMA"},{"key":"9905_CR35","doi-asserted-by":"crossref","first-page":"204589401879045","DOI":"10.1177\/2045894018790450","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang W, Hu X, Liao W et al (2019) The efficacy and safety of pulmonary vasodilators in patients with Fontan circulation: a meta-analysis of randomized controlled trials. Pulm Circ 9:2045894018790450","journal-title":"Pulm Circ"},{"key":"9905_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/CIRCIMAGING.113.001243","volume":"7","author":"A Van De Bruaene","year":"2014","unstructured":"Van De Bruaene A, La Gerche A, Claessen G et al (2014) Sildenafil improves exercise hemodynamics in Fontan patients. Circ Cardiovasc Imaging 7:265\u2013273","journal-title":"Circ Cardiovasc Imaging"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10741-019-09905-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10741-019-09905-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,12]],"date-time":"2021-02-12T06:03:51Z","timestamp":1613109831000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10741-019-09905-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,16]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["9905"],"URL":"https:\/\/doi.org\/10.1007\/s10741-019-09905-y","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,16]]},"assertion":[{"value":"16 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.This study was registered on PROSPERO (<b>CRD42019132135<\/b>).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}